Ligand validation:4BRG

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BRG_MES_B_1399	99%	13%	0.061	0.988	1.72	2.42	3	3	0	0	100%	1
4BRG_MES_A_1395	94%	11%	0.081	0.982	1.45	2.84	2	4	0	0	100%	1
4BRI_MES_B_1397	96%	19%	0.074	0.983	1.75	1.87	1	4	0	0	100%	1
4BRC_MES_A_1398	95%	26%	0.082	0.986	1.32	1.83	2	4	0	0	100%	1
4BRF_MES_B_1398	94%	8%	0.083	0.982	2.28	2.48	2	5	2	0	100%	0.75
4BRA_MES_B_1395	91%	17%	0.101	0.989	1.98	1.84	1	5	0	0	100%	0.75
4BRD_MES_B_1398	89%	9%	0.093	0.971	1.76	2.82	3	4	0	0	100%	0.9
8AJQ_MES_H_201	100%	39%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	25%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	24%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	61%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1
5W98_MES_A_401	98%	33%	0.063	0.989	1.41	1.33	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.